ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 382046 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 382046; 2) Community: the network communities that were significantly associated with the response to NSC 382046; 3) Molecule: the relationships between components within communities and NSC 382046; 4) MDR: the compounds that were significantly associated with the NSC 382046.

NSC Compound Enrichment Correlation
NSC 269721 Androstan-3-one, 17-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (5.alpha.,17.beta.)- 4.20634348588214e-005 0.54080575
NSC 740 Methotrexate 4.2063434858822e-005 0.9116755
NSC 382050 2,4-Pyrimidinediamine, 5-(3-azido-4-chlorophenyl)- 6-ethyl-, monoethanesulfonate 4.35666174401505e-006 0.60677269
NSC 701748 Null 4.35666174401505e-006 0.63764589
NSC 695938 Null 4.54580437744686e-005 0.52376897
NSC 716915 Null 4.54580437744686e-005 0.34796625
NSC 726769 5,6-Dihydro-6-(4-amino-1-butyl)-5,11-dioxo-11H-indeno{1,2-c] isoquinoline Hydrochloride 4.54580437744686e-005 0.65380573
NSC 755427 Null 4.54580437744686e-005 0.64915693
NSC 132275 Ethanesulfonic acid, compd. with 2-(2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenoxy)acetanilide (1:1) 4.5458043774469e-005 0.69621587
NSC 372939 Null 4.5458043774469e-005 0.6700247
Total:145  Current:144    [First] [Prev] [Next] [Last]